- Home
- NVFY vs CYCC Comparison
NVFY vs CYCC Comparison
Compare NVFY & CYCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- NVFY
- CYCC
- Stock Information
- Founded
- NVFY 2003
- CYCC 1992
- Country
- NVFY United States
- CYCC United States
- Employees
- NVFY N/A
- CYCC N/A
- Industry
- NVFY Home Furnishings
- CYCC Biotechnology: Pharmaceutical Preparations
- Sector
- NVFY Consumer Discretionary
- CYCC Health Care
- Exchange
- NVFY Nasdaq
- CYCC Nasdaq
- Market Cap
- NVFY 3.9M
- CYCC 3.6M
- IPO Year
- NVFY N/A
- CYCC N/A
- Fundamental
- Price
- NVFY $0.68
- CYCC $0.27
- Analyst Decision
- NVFY
- CYCC Strong Buy
- Analyst Count
- NVFY 0
- CYCC 1
- Target Price
- NVFY N/A
- CYCC $11.00
- AVG Volume (30 Days)
- NVFY 1.7M
- CYCC 202.6K
- Earning Date
- NVFY 05-14-2025
- CYCC 05-13-2025
- Dividend Yield
- NVFY N/A
- CYCC N/A
- EPS Growth
- NVFY N/A
- CYCC N/A
- EPS
- NVFY N/A
- CYCC N/A
- Revenue
- NVFY $9,686,975.00
- CYCC $74,000.00
- Revenue This Year
- NVFY N/A
- CYCC N/A
- Revenue Next Year
- NVFY N/A
- CYCC $88.68
- P/E Ratio
- NVFY N/A
- CYCC N/A
- Revenue Growth
- NVFY N/A
- CYCC N/A
- 52 Week Low
- NVFY $0.39
- CYCC $0.26
- 52 Week High
- NVFY $3.73
- CYCC $4.00
- Technical
- Relative Strength Index (RSI)
- NVFY 61.06
- CYCC 37.24
- Support Level
- NVFY $0.64
- CYCC $0.27
- Resistance Level
- NVFY $0.75
- CYCC $0.32
- Average True Range (ATR)
- NVFY 0.10
- CYCC 0.02
- MACD
- NVFY 0.02
- CYCC -0.00
- Stochastic Oscillator
- NVFY 71.71
- CYCC 16.50
About NVFY Nova Lifestyle Inc.
Nova Lifestyle Inc is a designer and lifestyle furniture company. It distributes and retails contemporary styled residential and commercial furniture. The firms marketing and sales platform offers retail as well as online selection and purchase fulfillment internationally. The company also sells managed a variety of bedding foundation components. Its collection of lifestyle furniture brands includes Diamond Sofa. The firm's products are made in the United States and Asia. Its customers mainly comprise distributors and retailers having specific geographic coverages that deploy middle to high-end private label home furnishings. The company operates in one business and industry segment: the design and sale of furniture.
About CYCC Cyclacel Pharmaceuticals Inc.
Cyclacel Pharmaceuticals Inc is a clinical-stage biopharmaceutical company that develops targeted medicines for cancer and other proliferative diseases. The company develops several families of anticancer drugs that act on the cell cycle, including CDK (cyclin-dependent kinase) inhibitors, and PLK (polo-like kinase) inhibitors. The pipeline development programs of the company include fadraciclib, Sapacitabine, and plogosertib.